Upadacitinib
Brand names: Rinvoq
Drug class: Janus Kinase Inhibitor
Prescription only
What is upadacitinib used for?
- Rheumatoid arthritis
RINVOQ/RINVOQ LQ is a Janus kinase (JAK) inhibitor. RINVOQ is indicated for the treatment of adults with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to one or more TNF blockers. ( 1.1 ) Limitations of Use RINVOQ is not recommended for use in combination with other JAK inhibitors, biologic DMARDs, or with potent immunosuppressants such as azathioprine and cyclosporine. ( 1.1 ) RINVOQ/RINVOQ LQ is indicated for the treatment of adults and pediatric patients 2 years of age and older with active psoriatic arthritis who have had an inadequat…
Upadacitinib price
Generic: No generic price listed.
Brand: Rinvoq: from $229 each, about $6,879 for 30 (30 mg tablet (ER)).
Compare upadacitinib
- Upadacitinib vs Methotrexate
- Upadacitinib vs Hydroxychloroquine
- Upadacitinib vs Sulfasalazine
- Upadacitinib vs Leflunomide
- Upadacitinib vs Tofacitinib